Thanks to a large number of transplants and collections and a prosperous year on the stock market, Swiss Transfusion SRC closed the year with a profit of CHF 88,111.
Employee turnover was low, and for the few positions that did need to be filled, Swiss Transfusion SRC had the privilege of selecting from a large pool of highly qualified applicants. This testifies to the special value attached to the work of Swiss Transfusion SRC: for many applicants, a sense of purpose is a key criterion.
Constancy does not mean stasis in this case. Progress is manifest in the ways that Swiss Transfusion SRC appreciates its employees. The staff is made up of committed individuals who go that extra mile when it counts. At the same time, it is the responsibility of the organisation to look closely at whether a burden is temporary or will continue for the long term. Maintaining this balance is an ongoing challenge.
«If 61 of a total of 64 employees choose to attend a voluntary Christmas party, then that makes me very happy. I want to keep that going.»
Rahel Vaterlaus, Head of Human Resources
Number of employees (as of 31 Dec. 2024): 64 permanent employees (up 3 from 2023), corresponding to a total of 49 FTE (up 2.9 FTE). The FTE figure includes three commercial apprentices (up 2). Around 81 per cent (down 8 per cent) of all personnel work on a part-time basis (40–90 per cent); the average FTE is 76 per cent. The average employee age is 45 (down 1), the average length of service is 6.1 years (up 0.3).
Voluntary turnover rate for 2024: This rate came in at a low 6.4 per cent in 2024 (2023: 9.6 per cent). This is within the range associated with healthy turnover, which various sources place at between 5 and 15 per cent. Twelve new employees were hired (up 7 from 2023). The overall turnover rate, which includes all departures (retirements, temporary appointments, employer-initiated terminations) came in at 9.6 per cent in 2024 (2023: 14.3 per cent).
Absence rate for 2024: The absence rate, total hours of absence due to illness / accidents / medical appointments calculated as a percentage of regular working hours, in 2024 was 2.9 per cent (up 0.4 per cent from 2023). Though rising, this rate is still well below the average Swiss health-related absence rate of 3.4 per cent (source: bfs, 2023 survey, publ. July 2024).
There were no changes in the management team and the board of Directors of Swiss Transfusion in 2024.
» To the overview
Over the course of two days, Swiss Transfusion SRC showed the lead auditor from SQS how the organisation lives its values, manages its processes, meets its responsibilities, performs its tasks and implements its projects, as well as how it deals with changes, deviations and risk.
The audit was successfully completed with no non-conformities detected.
Swiss Transfusion SRC is an autonomous organisation within the Swiss Red Cross (SRC) that is structured as a non-profit-making company limited by shares (gemeinnützige Aktiengesellschaft). The majority of its shares are owned by the SRC; the remaining 49 per cent are held by the eleven regional blood transfusion services (RBSD). Along with the RBSD, Swiss Transfusion SRC is responsible for managing the blood supply on behalf of the SRC. It also holds a mandate from the Swiss Government to manage the registry of blood stem cell donors, though no funding is provided for expanding the registry. Swiss Transfusion SRC has to rely on monetary donations to meet those costs.